Schedule of Well Child Checks

Immunization/Lab tests/Screenings
Hep B#1, neonatal screen
1 week
Hep B#1, repeat neonatal screen at 1 to 3 weeks
1 month
Hep B#1
2 months
Pentacel#1 (DTaP/IPV/HIB) – Prevnar#1 – Rotateq#1 – Hep B#1 or #2
4 months
Pentacel#2 – Prevnar#2 – Rotateq#2 – Hep B#2 if needed
6 months
Pentacel#3 – Prevnar#3 – Rotateq#3
9 months
Hep B#3
12 months
Hep A#1 – MMR#1 – Varivax#1 – HIB#4
CBC – lead screening – Mantoux TB skin test
15 months
DTaP#4 – Prevnar#4
18 months
“Catch-up” immunizations – Hep A#2
M-CHAT test (Modified Checklist for Autism in Toddlers)
24 months
Hep A#2 – M-CHAT – Hct – Lead screening
30 months
“Catch-up” immunizations if needed
36 months
Vision test if possible – UA if possible
4 years
Kinrix (DTaP/IPV) – MMRV – Vison/Hearing screenings
Hct – Mantoux – UA
5-10 years
Immunizations and tests as needed
HPV#1 – HPV#2 two months after #1 and HPV#3 six months after #1
Tdap#1 – Menactra#1
Hct- Mantoux – UA – cholesterol screening
Vision/Hearing screenings
12-15 years
Immunizations and tests as needed – annual Hct
16 to 18 years
Menactra#2 – Hct – Mantoux – UA – Cholesterol screening
19 to 21 years
Immunizations and tests as needed
Please note:
  1. “Catch-up” immunizations at any Well Child Check or mild to moderately ill sick child visit
  2. Individualized laboratory testing will be performed whenever necessary for our children
  3. Prevnar-13: One dose for every child who has not had it up to the 18th birthday
  4. Hct, Mantoux, UA, and if old enough, Vision/Hearing screening for new patients at their first Well Child Check
Explanation of Vaccines
Diptheria, Tetanus and Pertussis vaccine containing a full dose of diphtheria and tetanus toxoids and a full dose of acellular pertussis (“whooping cough”) vaccine. The acellular pertussis vaccine is a subunit vaccine consisting of pertussis toxoid and one or more other antigens of the Bordetella pertussis bacterium.
Hep A
Hepatits A vaccine, an inactivated (killed) whole virus vaccine
Hep B
Hepatitis B vaccine, a noninfectious subunit viral vaccine derived from Hepatitis B surface antigen and produced in yeast cells
Hemophilus Influenzae Type b vaccine, a polysaccharide vaccine conjugated to a tetanus toxoid
Human Papillomavirus Quadrivalent recombinant vaccine containing serotypes 6, 11, 16 and 18
Inactivated Poliovirus Vaccine, a killed virus vaccine
Meningococcal Conjugate Vaccine (MCV-4) containing serogroups A, C, W-135 and Y conjugated to a diphtheria toxoid
Measles, Mumps and Rubella vaccine developed from live-attenuated viruses
Pneumococcal Conjugate Vaccine (PCV-13) containing 13 serotypes of the Streptococcus pneumoniae bacterium conjugated to a diphtheria toxoid
Rotavirus vaccine, a pentavalent (RV-5) vaccine from live-attenuated viruses
Tetanus, diphtheria and acellular pertussis vaccine containing a full dose of tetanus toxoid with reduced doses of diphtheria toxoid and acellular pertussis vaccine
Varicella (“chicken pox”) vaccine, a live- attenuated vaccine